Get the Stockscreener App
1.05
5.52%
0.0549
iBio Inc stock is traded at $1.05, with a volume of 677.56K.
It is up +5.52% in the last 24 hours and down -5.41% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.9951
Open:
$1
24h Volume:
677.56K
Relative Volume:
0.21
Market Cap:
$23.61M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1583
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
-9.48%
1M Performance:
-5.41%
6M Performance:
+36.29%
1Y Performance:
-57.14%
1-Day Range:
$0.961
$1.07
1-Week Range:
$0.961
$1.277
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.05 | 22.38M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Oppenheimer | Outperform |
| Oct-17-25 | Initiated | Leerink Partners | Outperform |
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
View All
iBio Inc Stock (IBIO) Latest News
iBio Confirms Directors and Auditor at Annual Meeting - TipRanks
iBio shareholders elect directors and approve annual meeting proposals - Investing.com
How robust is iBio Inc. (0JV0) stock financial position2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Can trapped investors hope for a rebound in iBio Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
iBio, Inc. (IBIO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How iBio Inc. (0JV0) stock responds to job market shiftsJobs Report & Momentum Based Trading Signals - newser.com
Is iBio Inc. stock safe for conservative investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
Why hedge funds are buying iBio Inc. stockJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Will iBio Inc. stock deliver better than expected guidanceMarket Volume Summary & Stock Portfolio Risk Management - newser.com
Why iBio Inc. (0JV0) stock trades below fair valueWeekly Risk Report & Verified Entry Point Signals - newser.com
Is iBio Inc. (0JV0) stock supported by free cash flowJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock is rated strong buyTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Why analysts raise outlook for iBio Inc. (0JV0) stock2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock appeals to dividend seekersJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Is iBio Inc. (0JV0) stock a fit for income portfoliosEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Why iBio Inc. (0JV0) stock could be next leaderPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Is iBio Inc. (0JV0) stock a top dividend aristocrat candidate - newser.com
Using AI based signals to follow iBio Inc.2025 Pullback Review & Risk Managed Trade Strategies - newser.com
What high frequency data says about iBio Inc.Quarterly Risk Review & Technical Entry and Exit Tips - newser.com
iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Certain Warrants of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Prefunded Warrants of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Restricted Stock Units of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Options of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
[8-K] iBio, Inc. Reports Material Event | IBIO SEC FilingForm 8-K - Stock Titan
iBio, Inc. Reports Q3 2025 Financial Results - MSN
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):